BR9708790A - Composto uso de um composto e formulação farmacêutica - Google Patents
Composto uso de um composto e formulação farmacêuticaInfo
- Publication number
- BR9708790A BR9708790A BR9708790A BR9708790A BR9708790A BR 9708790 A BR9708790 A BR 9708790A BR 9708790 A BR9708790 A BR 9708790A BR 9708790 A BR9708790 A BR 9708790A BR 9708790 A BR9708790 A BR 9708790A
- Authority
- BR
- Brazil
- Prior art keywords
- compound
- pharmaceutical formulation
- compound use
- formulation
- pharmaceutical
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- General Health & Medical Sciences (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP96201065 | 1996-04-19 | ||
| PCT/EP1997/001904 WO1997040027A1 (en) | 1996-04-19 | 1997-04-15 | Substituted benzylamines and their use for the treatment of depression |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9708790A true BR9708790A (pt) | 1999-08-03 |
Family
ID=8223896
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9708790A BR9708790A (pt) | 1996-04-19 | 1997-04-15 | Composto uso de um composto e formulação farmacêutica |
Country Status (25)
| Country | Link |
|---|---|
| EP (1) | EP0898566B1 (pt) |
| JP (1) | JP4008033B2 (pt) |
| CN (1) | CN1139580C (pt) |
| AR (1) | AR006719A1 (pt) |
| AT (1) | ATE227278T1 (pt) |
| AU (1) | AU725847B2 (pt) |
| BR (1) | BR9708790A (pt) |
| CA (1) | CA2251820C (pt) |
| CZ (1) | CZ295747B6 (pt) |
| DE (1) | DE69716896T2 (pt) |
| DK (1) | DK0898566T3 (pt) |
| ES (1) | ES2186888T3 (pt) |
| HK (1) | HK1018271A1 (pt) |
| HU (1) | HU224637B1 (pt) |
| ID (1) | ID17723A (pt) |
| IL (1) | IL120669A (pt) |
| NO (1) | NO311976B1 (pt) |
| NZ (1) | NZ332334A (pt) |
| PL (1) | PL192561B1 (pt) |
| PT (1) | PT898566E (pt) |
| RU (1) | RU2179553C2 (pt) |
| TR (1) | TR199802104T2 (pt) |
| TW (1) | TW498070B (pt) |
| WO (1) | WO1997040027A1 (pt) |
| ZA (1) | ZA973209B (pt) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6080773A (en) * | 1997-10-14 | 2000-06-27 | Akzo Nobel, N.V. | Benzylamine derivatives which are useful in treating psychiatric disorders |
| US6342533B1 (en) * | 1998-12-01 | 2002-01-29 | Sepracor, Inc. | Derivatives of (−)-venlafaxine and methods of preparing and using the same |
| IL148622A0 (en) * | 1999-09-14 | 2002-09-12 | Aventis Pharm Prod Inc | Benzisoxazolyl-pyridoisoxazolyl-and benzthienyl-phenoxy derivatives useful as d4 antagonists |
| US7091199B1 (en) | 1999-09-14 | 2006-08-15 | Aventis Pharmaceuticals Inc. | Thienoisoxazole phenoxy unsubstituted ethyl and propyl derivatives useful as d4 antagonists |
| US7253165B2 (en) | 1999-09-14 | 2007-08-07 | Aventis Pharmaceuticals Inc. | Benzisoxazolyl-, pyridoisoxazolyl-and benzthienyl-phenoxy derivatives useful as D4 antagonists |
| US7125903B1 (en) | 1999-09-14 | 2006-10-24 | Aventis Pharmaceuticals Inc. | Thienoisoxazolyl-and thienylpyrrazolyl-phenoxy substituted propyl derivatives useful as D4 antagonists |
| GB0321538D0 (en) | 2003-09-13 | 2003-10-15 | Glaxo Group Ltd | Therapeutically useful compounds |
| EP1925305A1 (en) * | 2006-10-23 | 2008-05-28 | N.V. Organon | Ih channel inhibitors for the promotion of wakefulness |
| NZ593282A (en) * | 2008-12-24 | 2013-06-28 | Astrazeneca Ab | Ethanamine compounds and their use for treating depression |
| EP2473489B1 (en) | 2009-07-07 | 2013-08-21 | Merck Sharp & Dohme B.V. | 2-(1,2-benzisoxazol-3-yl)benzylamine derivatives |
| CN102942464B (zh) * | 2012-12-06 | 2015-04-08 | 西北师范大学 | 化合物1-(2-卤苯基)-3-甲基-丁酮-1的合成方法 |
| CN112300061B (zh) * | 2020-10-06 | 2022-02-18 | 大连理工大学 | 一种含氮杂环二芳酮化合物的制备方法 |
| GB202103008D0 (en) | 2021-03-03 | 2021-04-14 | King S College London | Compounds |
| GB202103012D0 (en) | 2021-03-03 | 2021-04-14 | King S College London | Compounds |
| GB202103017D0 (en) | 2021-03-03 | 2021-04-14 | King S College London | Compounds |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4980365A (en) * | 1987-07-13 | 1990-12-25 | Hoechst-Roussel Pharmaceuticals Inc. | N-substituted-5,6-dimethoxy-1,2-benzisoxazole-3-propanamine and related compounds as analgesic and hypotensive agents |
| FR2680366B1 (fr) * | 1991-08-13 | 1995-01-20 | Adir | Nouveaux derives d'arylethylamines, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent. |
-
1997
- 1997-04-15 ES ES97919371T patent/ES2186888T3/es not_active Expired - Lifetime
- 1997-04-15 DK DK97919371T patent/DK0898566T3/da active
- 1997-04-15 AU AU23870/97A patent/AU725847B2/en not_active Expired
- 1997-04-15 CA CA002251820A patent/CA2251820C/en not_active Expired - Lifetime
- 1997-04-15 PT PT97919371T patent/PT898566E/pt unknown
- 1997-04-15 TR TR1998/02104T patent/TR199802104T2/xx unknown
- 1997-04-15 BR BR9708790A patent/BR9708790A/pt not_active Application Discontinuation
- 1997-04-15 CN CNB971947376A patent/CN1139580C/zh not_active Expired - Lifetime
- 1997-04-15 CZ CZ19983349A patent/CZ295747B6/cs not_active IP Right Cessation
- 1997-04-15 NZ NZ332334A patent/NZ332334A/en not_active IP Right Cessation
- 1997-04-15 PL PL329348A patent/PL192561B1/pl not_active IP Right Cessation
- 1997-04-15 HU HU9901434A patent/HU224637B1/hu not_active IP Right Cessation
- 1997-04-15 ZA ZA9703209A patent/ZA973209B/xx unknown
- 1997-04-15 EP EP97919371A patent/EP0898566B1/en not_active Expired - Lifetime
- 1997-04-15 JP JP53769997A patent/JP4008033B2/ja not_active Expired - Lifetime
- 1997-04-15 DE DE69716896T patent/DE69716896T2/de not_active Expired - Lifetime
- 1997-04-15 RU RU98120691/04A patent/RU2179553C2/ru not_active IP Right Cessation
- 1997-04-15 IL IL12066997A patent/IL120669A/en not_active IP Right Cessation
- 1997-04-15 AT AT97919371T patent/ATE227278T1/de active
- 1997-04-15 WO PCT/EP1997/001904 patent/WO1997040027A1/en active IP Right Grant
- 1997-04-19 TW TW086105111A patent/TW498070B/zh not_active IP Right Cessation
- 1997-04-21 ID IDP971328A patent/ID17723A/id unknown
- 1997-04-21 AR ARP970101597A patent/AR006719A1/es active IP Right Grant
-
1998
- 1998-10-16 NO NO19984836A patent/NO311976B1/no not_active IP Right Cessation
-
1999
- 1999-08-02 HK HK99103314A patent/HK1018271A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9706311A (pt) | Compostos de estilbeno composição farmacêutica composição cosmética e uso de uma composição cosmética | |
| BR9500784A (pt) | Composto e formulação farmacêutica | |
| BR9504060A (pt) | Composto e formulação farmacêutica | |
| BR9707501A (pt) | Composto composição farmacêutica e uso do composto | |
| BR1100329A (pt) | Composto e formulação farmacêutica | |
| DE69525148D1 (de) | Pharmazeutische formulierung | |
| KR950703566A (ko) | 티에노디아제핀 화합물 및 그의 의약 용도[thienodiazepine compound and medicinal use thereof] | |
| ID24654A (id) | Formulasi farmasi omeprazola | |
| BR9802130A (pt) | Compostos triaromáticos composição farmacêutica composição cosmética e uso de uma composição cosmética | |
| BR9602705A (pt) | Composto composição farmacéutica processo para a preparação de um composto e uso | |
| BR9611367A (pt) | Formulação farmacêutic liofilizada estável | |
| NO954486D0 (no) | Farmasöytiske formuleringsgrunnlag | |
| BR9707812A (pt) | Composto composto farmacêutica e uso do composto | |
| NO981008D0 (no) | Farmasöytisk formulering | |
| BR9602915A (pt) | Medicamentos uso e formulação farmacêutica | |
| BR9711191A (pt) | Composto e uso do mesmo | |
| BR9707808A (pt) | Composto composição farmacêutica e uso do composto | |
| ID22523A (id) | Formulasi aerosol obat yang mengandung budesonida | |
| BR9510229A (pt) | Uso de um derivado 2-alquil ou 2-aralquil-bit e composição | |
| BR9708790A (pt) | Composto uso de um composto e formulação farmacêutica | |
| BR9610821A (pt) | Derivado de aminoácido uso de um composto e medicamento contendo o mesmo | |
| BR9600688A (pt) | Compostos heterocíclicos aromáticos composição farmacêutica uso de um composto e composição cosmética | |
| BR9612413A (pt) | Composto uso do mesmo e composição farmacêutica | |
| BR9800718A (pt) | Composto esteróide composição farmacéutica uso de um composto esteróide e processo para a preparação de um estróide | |
| BR9608896A (pt) | Derivados de oxazolidinona sua preparação e uso terapêutico |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: INDEFERIMENTO DO PRESENTE PEDIDO, UMA VEZ QUE INCIDE NOS ARTIGOS 8O, 13, 24, E 25 DA LPI. |
|
| B12B | Appeal against refusal [chapter 12.2 patent gazette] |